• Most Popular
  • Most Shared

Sun Pharma gets U.S. nod for prostate cancer drug

Tue Jul 7, 2009 10:59am EDT

Stocks

   

BANGALORE, July 7 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO) said on Tuesday it had received approval from the U.S. Food and Drug Administration to launch generic version of AstraZeneca Plc's (AZN.L) prostate cancer drug Casodex.

The Indian drug maker said in a statement that AstraZeneca (AZN.L) had annual sales of Casodex of $314 million in the United States.

Ahead of the announcement, shares in Sun Pharma rose 1.2 percent to 1,143.35 rupees in the main Mumbai market .BSESN that ended 0.9 percent higher. (Reporting by Sumeet Chatterjee; Editing by David Cowell)



More from Reuters

Photo

U.S. home sales bolster economic growth prospects

WASHINGTON (Reuters) - Sales of previously owned U.S. homes jumped to the highest level in nearly three years last month, the latest sign the economic recovery was gaining steam after growing below expectations in the third quarter.

» More Top News
Guadalupe Hernandez receives an ultrasound by nurse practitioner Gail Brown during a prenatal exam at the Maternity Outreach Mobile in Phoenix, Arizona October 8, 2009. Credit: REUTERS/Joshua Lott

Health reform inches closer

Democrats are on the verge of passing landmark legislation by Christmas, with only one more hurdle remaining.  Full Article | Video 

Healthcare Reform
Two men is reflected on a glass wall of Exhibitions Central in Dubai December 21, 2009, where Dubai World's western bank creditors are meeting. REUTERS/Ahmed Jadallah
Analysis:

Dubai, it's time to get creative

Scrambling to rebuild its image after a $26 billion debt bombshell, Dubai needs to raise cash without the PR nightmare of raising taxes.  Full Article 

Global Markets